Viewing Study NCT04183712


Ignite Creation Date: 2025-12-26 @ 10:46 PM
Ignite Modification Date: 2026-03-05 @ 7:27 AM
Study NCT ID: NCT04183712
Status: RECRUITING
Last Update Posted: 2024-10-16
First Post: 2019-11-28
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Target Therapy With GEMOX in Recectable Gallbladder Carcinoma Patients Monitored by ctDNA
Sponsor: Shanghai Jiao Tong University School of Medicine
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: LTGBCLYB2019
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None OTHER View
None OTHER View
None OTHER View
None OTHER View
None OTHER View
None OTHER View
None OTHER View
None OTHER View
None UNKNOWN View
None OTHER View
None OTHER View
None UNKNOWN View